Core Viewpoint - Xiansheng Pharmaceutical (02096) experienced a significant stock price increase of 8.69% on August 22, reaching a price of 13.88 CNY per share with a trading volume of 12.0488 million CNY [1] Company Overview - Xiansheng Pharmaceutical Group Co., Ltd. is a pharmaceutical company driven by innovation and research, focusing on developing and producing more effective drugs to meet patient needs [1] Financial Performance - As of the mid-year report for 2025, Xiansheng Pharmaceutical reported total revenue of 3.585 billion CNY and a net profit of 604 million CNY [1] - For the fiscal year 2025 mid-year report, the profit attributable to shareholders was 603.6 million CNY, representing a year-on-year growth of 32.2%, with basic earnings per share of 0.25 CNY [1]
先声药业(02096)上涨8.69%，报13.88元/股